Xvivo Perfusion: Positive results from the PrimECC study

Research Note

2018-05-14

17:44

The analysis of the clinical trial with PrimECC showed positive findings. PrimECC continued to show a good safety profile and reduced the side effects when used as a priming solution for heart-lung machines. Today's news will not result in any changes in our valuation of the company, but we see that further development is warranted.

AN

Arvid Necander

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.